All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) · Represents pharmaceutical research and biotechnology companies

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 4

Medicare/Medicaid

Legislative issues related to access to pharmaceuticals; Rebates in Medicaid and for dual-eligibles; Medicaid coverage issues; 340B Drug Program; Medicare Part B and D prescription drug reimbursement. Pharmacy Benefit Management Reform in Medicare Part D, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Health Issues

Monitor implementation of the 340B Prescription Drug Discount Program and implementation of the Inflation Reduction Act of 2022 (P.L. No: 117-169). Issues regarding FDA user fee programs. Pharmacy Benefit Management Reform. Public health issues impacting patient access to treatments.

Trade (domestic/foreign)

Issues related to trade enforcement and protection. Issues related to TRIPS waivers (Trade-Related Aspects of Intellectual Property Rights).

Defense

Issues related to the FY26 National Defense Authorization Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.